Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Multiple Myeloma 3Leukemia, Myeloid, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Congenital Abnormalities 2Anemia, Refractory, with Excess of Blasts 2Thrombocythemia, Essential 1Polycythemia Vera 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1Blast Crisis 1

Interventions

Imatinib Mesylate 10Cyclophosphamide 9fludarabine 8nilotinib 7fludarabine phosphate 7Dasatinib 6Busulfan 6Whole-Body Irradiation 5Tacrolimus 5Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5Melphalan 5Cytarabine 5Stem Cell Transplantation 4Filgrastim 4Alemtuzumab 4Cyclosporine 3Bone Marrow Transplantation 3Antilymphocyte Serum 3thymoglobulin 2ruxolitinib 2ponatinib 2plerixafor 2bosutinib 2Thiotepa 2Sirolimus 2Granulocyte Colony-Stimulating Factor 2Everolimus 2venetoclax 1vatalanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Transplantation × Clear all
NCT00809276 2015-02-16

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
92 enrolled 5 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡